CVS Stock Overview
CVS Health Corporation provides health services in the United States.
CVS Health Competitors
Price History & Performance
|Historical stock prices|
|Current Share Price||US$97.21|
|52 Week High||US$111.25|
|52 Week Low||US$81.78|
|1 Month Change||-2.85%|
|3 Month Change||4.14%|
|1 Year Change||13.48%|
|3 Year Change||55.91%|
|5 Year Change||20.15%|
|Change since IPO||759.31%|
Recent News & Updates
CVS Health declares $0.55 dividend
CVS Health (NYSE:CVS) declares $0.55/share quarterly dividend, in line with previous. Forward yield 2.21% Payable Nov. 1; for shareholders of record Oct. 21; ex-div Oct. 20. See CVS Dividend Scorecard, Yield Chart, & Dividend Growth.
Does CVS Health (NYSE:CVS) Have A Healthy Balance Sheet?
Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...
|CVS||US Healthcare||US Market|
Return vs Industry: CVS exceeded the US Healthcare industry which returned 5.3% over the past year.
Return vs Market: CVS exceeded the US Market which returned -23.7% over the past year.
|CVS Average Weekly Movement||3.2%|
|Healthcare Industry Average Movement||8.3%|
|Market Average Movement||6.9%|
|10% most volatile stocks in US Market||15.7%|
|10% least volatile stocks in US Market||2.8%|
Stable Share Price: CVS is less volatile than 75% of US stocks over the past 3 months, typically moving +/- 3% a week.
Volatility Over Time: CVS's weekly volatility (3%) has been stable over the past year.
About the Company
CVS Health Corporation provides health services in the United States. The company’s Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services. It serves employer groups, individuals, college students, part-time and hourly workers, health plans, health care providers, governmental units, government-sponsored plans, labor groups, and expatriates.
CVS Health Fundamentals Summary
|CVS fundamental statistics|
Is CVS overvalued?See Fair Value and valuation analysis
Earnings & Revenue
|CVS income statement (TTM)|
|Cost of Revenue||US$254.40b|
Last Reported Earnings
Jun 30, 2022
Next Earnings Date
Nov 02, 2022
|Earnings per share (EPS)||6.22|
|Net Profit Margin||2.66%|
How did CVS perform over the long term?See historical performance and comparison
2.3%Current Dividend Yield
Does CVS pay a reliable dividends?See CVS dividend history and benchmarks
|CVS Health dividend dates|
|Ex Dividend Date||Oct 20 2022|
|Dividend Pay Date||Nov 01 2022|
|Days until Ex dividend||21 days|
|Days until Dividend pay date||33 days|
Does CVS pay a reliable dividends?See CVS dividend history and benchmarks
Is CVS undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score 6/6
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Below Fair Value
Significantly Below Fair Value
Key Valuation Metric
Which metric is best to use when looking at relative valuation for CVS?
Other financial metrics that can be useful for relative valuation.
|What is CVS's n/a Ratio?|
Price to Earnings Ratio vs Peers
How does CVS's PE Ratio compare to its peers?
|CVS PE Ratio vs Peers|
|Company||PE||Estimated Growth||Market Cap|
LH Laboratory Corporation of America Holdings
DGX Quest Diagnostics
RCM R1 RCM
CVS CVS Health
Price-To-Earnings vs Peers: CVS is good value based on its Price-To-Earnings Ratio (15.6x) compared to the peer average (39.5x).
Price to Earnings Ratio vs Industry
How does CVS's PE Ratio compare vs other companies in the US Healthcare Industry?
Price-To-Earnings vs Industry: CVS is good value based on its Price-To-Earnings Ratio (15.6x) compared to the US Healthcare industry average (18.4x)
Price to Earnings Ratio vs Fair Ratio
What is CVS's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
|Current PE Ratio||15.6x|
|Fair PE Ratio||37.9x|
Price-To-Earnings vs Fair Ratio: CVS is good value based on its Price-To-Earnings Ratio (15.6x) compared to the estimated Fair Price-To-Earnings Ratio (37.9x).
Share Price vs Fair Value
What is the Fair Price of CVS when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: CVS ($97.21) is trading below our estimate of fair value ($325.18)
Significantly Below Fair Value: CVS is trading below fair value by more than 20%.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Analyst Forecast: Target price is more than 20% higher than the current share price and analysts are within a statistically confident range of agreement.
Discover undervalued companies
How is CVS Health forecast to perform in the next 1 to 3 years based on estimates from 20 analysts?
Future Growth Score1/6
Future Growth Score 1/6
Earnings vs Savings Rate
Earnings vs Market
High Growth Earnings
Revenue vs Market
High Growth Revenue
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: CVS's forecast earnings growth (10.5% per year) is above the savings rate (1.9%).
Earnings vs Market: CVS's earnings (10.5% per year) are forecast to grow slower than the US market (14.7% per year).
High Growth Earnings: CVS's earnings are forecast to grow, but not significantly.
Revenue vs Market: CVS's revenue (4.8% per year) is forecast to grow slower than the US market (7.6% per year).
High Growth Revenue: CVS's revenue (4.8% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: CVS's Return on Equity is forecast to be low in 3 years time (14.8%).
Discover growth companies
How has CVS Health performed over the past 5 years?
Past Performance Score4/6
Past Performance Score 4/6
Growing Profit Margin
Earnings vs Industry
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: CVS has high quality earnings.
Growing Profit Margin: CVS's current net profit margins (2.7%) are higher than last year (2.6%).
Past Earnings Growth Analysis
Earnings Trend: CVS's earnings have grown by 16.5% per year over the past 5 years.
Accelerating Growth: CVS's earnings growth over the past year (13.2%) is below its 5-year average (16.5% per year).
Earnings vs Industry: CVS earnings growth over the past year (13.2%) exceeded the Healthcare industry 3.2%.
Return on Equity
High ROE: CVS's Return on Equity (10.8%) is considered low.
Discover strong past performing companies
How is CVS Health's financial position?
Financial Health Score3/6
Financial Health Score 3/6
Short Term Liabilities
Long Term Liabilities
Financial Position Analysis
Short Term Liabilities: CVS's short term assets ($62.1B) do not cover its short term liabilities ($68.5B).
Long Term Liabilities: CVS's short term assets ($62.1B) do not cover its long term liabilities ($86.3B).
Debt to Equity History and Analysis
Debt Level: CVS's net debt to equity ratio (50.9%) is considered high.
Reducing Debt: CVS's debt to equity ratio has reduced from 78.3% to 70.7% over the past 5 years.
Debt Coverage: CVS's debt is well covered by operating cash flow (34.7%).
Interest Coverage: CVS's interest payments on its debt are well covered by EBIT (9.9x coverage).
Discover healthy companies
What is CVS Health current dividend yield, its reliability and sustainability?
Dividend Score 5/6
Cash Flow Coverage
Current Dividend Yield
Upcoming Dividend Payment
Dividend Yield vs Market
|CVS Health Dividend Yield vs Market|
|Company (CVS Health)||2.3%|
|Market Bottom 25% (US)||1.7%|
|Market Top 25% (US)||4.7%|
|Industry Average (Healthcare)||1.4%|
|Analyst forecast in 3 Years (CVS Health)||2.4%|
Notable Dividend: CVS's dividend (2.26%) is higher than the bottom 25% of dividend payers in the US market (1.67%).
High Dividend: CVS's dividend (2.26%) is low compared to the top 25% of dividend payers in the US market (4.68%).
Stability and Growth of Payments
Stable Dividend: CVS's dividends per share have been stable in the past 10 years.
Growing Dividend: CVS's dividend payments have increased over the past 10 years.
Earnings Payout to Shareholders
Earnings Coverage: With its reasonably low payout ratio (33.9%), CVS's dividend payments are well covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: With its low cash payout ratio (18.2%), CVS's dividend payments are well covered by cash flows.
Discover strong dividend paying companies
How experienced are the management team and are they aligned to shareholders interests?
Average management tenure
Karen Lynch (59 yo)
Ms. Karen Sue Lynch serves as Chief Executive Officer, President and Director at CVS Health Corporation since February 01, 2021. She has extensive experience in the health care industry. She was Executive...
CEO Compensation Analysis
|Karen Lynch's Compensation vs CVS Health Earnings|
|Date||Total Comp.||Salary||Company Earnings|
|Jun 30 2022||n/a||n/a|
|Mar 31 2022||n/a||n/a|
|Dec 31 2021||US$20m||US$1m|
|Sep 30 2021||n/a||n/a|
|Jun 30 2021||n/a||n/a|
|Mar 31 2021||n/a||n/a|
|Dec 31 2020||US$11m||US$1m|
Compensation vs Market: Karen's total compensation ($USD20.39M) is above average for companies of similar size in the US market ($USD13.05M).
Compensation vs Earnings: Karen's compensation has increased by more than 20% in the past year.
Experienced Management: CVS's management team is not considered experienced ( 1.6 years average tenure), which suggests a new team.
Experienced Board: CVS's board of directors are considered experienced (7.5 years average tenure).
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Recent Insider Transactions
|17 Mar 22||SellUS$180,132||Prem Shah||Individual||1,689||US$106.65|
|10 Feb 22||BuyUS$105,904||Edward Ludwig||Individual||1,000||US$105.90|
|Owner Type||Number of Shares||Ownership Percentage|
|State or Government||583,357||0.04%|
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
|Ownership||Name||Shares||Current Value||Change %||Portfolio %|
CVS Health Corporation's employee growth, exchange listings and data sources
- Name: CVS Health Corporation
- Ticker: CVS
- Exchange: NYSE
- Founded: 1963
- Industry: Health Care Services
- Sector: Healthcare
- Implied Market Cap: US$127.620b
- Shares outstanding: 1.31b
- Website: https://www.cvshealth.com
Number of Employees
- CVS Health Corporation
- One CVS Drive
- Rhode Island
- United States
|Ticker||Exchange||Primary Security||Security Type||Country||Currency||Listed on|
|CVS||NYSE (New York Stock Exchange)||Yes||Common Stock||US||USD||Jan 1968|
|CVS||DB (Deutsche Boerse AG)||Yes||Common Stock||DE||EUR||Jan 1968|
|CVS||XTRA (XETRA Trading Platform)||Yes||Common Stock||DE||EUR||Jan 1968|
|CVS *||BMV (Bolsa Mexicana de Valores)||Yes||Common Stock||MX||MXN||Jan 1968|
|CVSCL||SNSE (Santiago Stock Exchange)||Yes||Common Stock||CL||CLP||Jan 1968|
|CVS||SNSE (Santiago Stock Exchange)||Yes||Common Stock||CL||USD||Jan 1968|
|0HRS||LSE (London Stock Exchange)||Yes||Common Stock||GB||USD||Jan 1968|
|CVS||ETLX (Eurotlx)||Yes||Common Stock||IT||EUR||Jan 1968|
|CVS||WBAG (Wiener Boerse AG)||Yes||Common Stock||AT||EUR||Jan 1968|
|CVS||BVL (Bolsa de Valores de Lima)||Yes||Common Stock||PE||USD||Jan 1968|
|CVSH34||BOVESPA (Bolsa de Valores de Sao Paulo)||BDR EACH 2 REP 1 COM||BR||BRL||Apr 2016|
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2022/09/27 00:00|
|End of Day Share Price||2022/09/27 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.